• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫球蛋白G上的Clq受体位点。

The Clq receptor site on immunoglobulin G.

作者信息

Burton D R, Boyd J, Brampton A D, Easterbrook-Smith S B, Emanuel E J, Novotny J, Rademacher T W, van Schravendijk M R, Sternberg M J, Dwek R A

出版信息

Nature. 1980 Nov 27;288(5789):338-44. doi: 10.1038/288338a0.

DOI:10.1038/288338a0
PMID:6776418
Abstract

We propose that, the binding site for the complement subcomponent Clq on immunoglobulin G involves the last two (C-terminal) beta-strands of the C gamma 2 domain. This region contains a large number of accessible and highly conserved charged residues and charge is postulated as an important component of the Clq-IgG interaction. The conclusions are reached on the basis of accessibility and sequence conservation analyses of C gamma 2 amino acid residues, the use of specific inhibitors and chemical modification studies.

摘要

我们提出,免疫球蛋白G上补体亚成分C1q的结合位点涉及Cγ2结构域的最后两条(C末端)β链。该区域含有大量可及的且高度保守的带电荷残基,并且电荷被假定为C1q-IgG相互作用的一个重要组成部分。这些结论是基于对Cγ2氨基酸残基的可及性和序列保守性分析、使用特异性抑制剂以及化学修饰研究而得出的。

相似文献

1
The Clq receptor site on immunoglobulin G.免疫球蛋白G上的Clq受体位点。
Nature. 1980 Nov 27;288(5789):338-44. doi: 10.1038/288338a0.
2
An IgG primary sequence exposure theory for complement activation using synthetic peptides.
Nature. 1979 Dec 13;282(5740):742-3. doi: 10.1038/282742a0.
3
Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.人免疫球蛋白G第二恒定结构域的单体和二聚体肽对C1介导的免疫溶血的抑制作用
J Immunol. 1981 Dec;127(6):2555-60.
4
Functional affinity constants of subfragments of immunoglobulin G for Clq.免疫球蛋白G亚片段与Clq的功能亲和常数
Mol Immunol. 1982 Jan;19(1):127-31. doi: 10.1016/0161-5890(82)90254-1.
5
Inhibition of the interaction between the complement component Clq and immune complexes.补体成分C1q与免疫复合物之间相互作用的抑制
Int Arch Allergy Appl Immunol. 1979;58(2):140-8. doi: 10.1159/000232186.
6
The C1q receptor site on human immunoglobulin G.
Can J Biochem Cell Biol. 1984 Jun;62(6):418-25. doi: 10.1139/o84-057.
7
Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.有证据表明,C1q 特异性结合自身抗原钙网蛋白中存在的 CH2 样免疫球蛋白γ基序,并干扰补体激活。
Biochemistry. 1998 Dec 22;37(51):17865-74. doi: 10.1021/bi973197p.
8
Multiple binding sites on the CH2 domain of IgG for mouse Fc gamma R11.IgG的CH2结构域上存在多个与小鼠FcγRII结合的位点。
Mol Immunol. 1992 Jan;29(1):53-9. doi: 10.1016/0161-5890(92)90156-r.
9
Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates.通过竞争性抑制Clq与不溶性IgG聚集体的结合来定量免疫复合物。
J Immunol Methods. 1977;15(1):39-45. doi: 10.1016/0022-1759(77)90015-1.
10
Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement.
Biochemistry. 1977 Jan 25;16(2):233-40. doi: 10.1021/bi00621a012.

引用本文的文献

1
Therapeutic antibodies in oncology: an immunopharmacological overview.肿瘤学中的治疗性抗体:免疫药理学概述。
Cancer Immunol Immunother. 2024 Oct 3;73(12):242. doi: 10.1007/s00262-024-03814-2.
2
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies.具有增强Fc效应功能的Fc工程化抗体用于治疗B细胞恶性肿瘤
Cancers (Basel). 2020 Oct 19;12(10):3041. doi: 10.3390/cancers12103041.
3
Complement Protein C1q Interacts with DC-SIGN Its Globular Domain and Thus May Interfere with HIV-1 Transmission.
补体蛋白C1q与DC-SIGN及其球状结构域相互作用,因此可能干扰HIV-1传播。
Front Immunol. 2016 Dec 22;7:600. doi: 10.3389/fimmu.2016.00600. eCollection 2016.
4
Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides.脑膜炎球菌荚膜多糖对补体经典途径的抑制作用。
J Immunol. 2014 Aug 15;193(4):1855-63. doi: 10.4049/jimmunol.1303177. Epub 2014 Jul 11.
5
Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.补体对 HIV-2 血浆抗病毒活性的影响具有同种型特异性和高效性。
J Virol. 2013 Jan;87(1):273-81. doi: 10.1128/JVI.01640-12. Epub 2012 Oct 17.
6
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.Fc 受体靶向疗法治疗炎症、癌症及其他疾病。
Nat Rev Drug Discov. 2012 Mar 30;11(4):311-31. doi: 10.1038/nrd2909.
7
Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions.工程化 Fc 变体抗体,具有增强募集补体和介导效应功能的能力。
MAbs. 2010 Mar-Apr;2(2):181-9. doi: 10.4161/mabs.2.2.11158.
8
The role of salivary and intestinal complement system inhibitors in the midgut protection of triatomines and mosquitoes.唾液和肠道补体系统抑制剂在锥蝽和蚊子中肠保护中的作用。
PLoS One. 2009 Jun 25;4(6):e6047. doi: 10.1371/journal.pone.0006047.
9
Porcine IgG: structure, genetics, and evolution.猪免疫球蛋白G:结构、遗传学与进化
Immunogenetics. 2009 Mar;61(3):209-30. doi: 10.1007/s00251-008-0336-9. Epub 2008 Dec 2.
10
Structural and functional anatomy of the globular domain of complement protein C1q.补体蛋白C1q球状结构域的结构与功能解剖学
Immunol Lett. 2004 Sep;95(2):113-28. doi: 10.1016/j.imlet.2004.06.015.